Terms: = Breast cancer AND MSI2, ENSG00000153944, 124540
9 results:
1. Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory breast cancer.
Haiduk TS; Sicking M; Brücksken KA; Espinoza-Sánchez NA; Eder KM; Kemper B; Eich HT; Götte M; Greve B; Troschel FM
Arch Med Res; 2023 Sep; 54(6):102855. PubMed ID: 37481823
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of cfDNA as an early detection assay for dense tissue breast cancer.
Barbirou M; Miller AA; Gafni E; Mezlini A; Zidi A; Boley N; Tonellato PJ
Sci Rep; 2022 May; 12(1):8458. PubMed ID: 35589867
[TBL] [Abstract] [Full Text] [Related]
3. RNA-binding protein complex LIN28/msi2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7.
Zou H; Luo J; Guo Y; Liu Y; Wang Y; Deng L; Li P
Oncogene; 2022 Mar; 41(11):1657-1672. PubMed ID: 35102250
[TBL] [Abstract] [Full Text] [Related]
4. Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative breast cancer Cells.
Valla S; Hassan N; Vitale DL; Madanes D; Spinelli FM; Teixeira FCOB; Greve B; Espinoza-Sánchez NA; Cristina C; Alaniz L; Götte M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070901
[TBL] [Abstract] [Full Text] [Related]
5. RNA-binding protein msi2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract] [Full Text] [Related]
6. Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative breast cancer.
Troschel FM; Minte A; Ismail YM; Kamal A; Abdullah MS; Ahmed SH; Deffner M; Kemper B; Kiesel L; Eich HT; Ibrahim SA; Götte M; Greve B
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245259
[TBL] [Abstract] [Full Text] [Related]
7. Stem Cells, cancer, and MUSASHI in Blood and Guts.
Kharas MG; Lengner CJ
Trends Cancer; 2017 May; 3(5):347-356. PubMed ID: 28718412
[TBL] [Abstract] [Full Text] [Related]
8. DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer.
Choi YM; Kim KB; Lee JH; Chun YK; An IS; An S; Bae S
Oncogene; 2017 May; 36(20):2802-2812. PubMed ID: 27941885
[TBL] [Abstract] [Full Text] [Related]
9. Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.
Kang MH; Jeong KJ; Kim WY; Lee HJ; Gong G; Suh N; Győrffy B; Kim S; Jeong SY; Mills GB; Park YY
Oncogene; 2017 Mar; 36(12):1745-1752. PubMed ID: 27593929
[TBL] [Abstract] [Full Text] [Related]
